Three Blood Biomarkers Predict Higher Risk of Heart Attack, Stroke in Women

Translate to Spanish or other 102 languages!

Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
- Advertisement -
  • Cardiovascular disease is the leading cause of death in women globally. 
  • There have historically been disparities in diagnosing cardiovascular disease in women as they may have no or different symptoms than men. 
  • Researchers from Brigham and Women’s Hospital found measuring three different biological blood markers can better predict a woman’s risk of having a major cardiovascular event over the next 30 years compared to measuring only one biomarker.

Cardiovascular disease is the leading cause of death in women around the globe, while stroke is the third most commonTrusted Source.

Follow the link to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/3-blood-biomarkers-predict-higher-risk-of-heart-attack-stroke-in-women?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Strategy Helps Immune System Fight High‑Grade Ovarian Cancer

Researchers at the University of California San Diego and collaborators have discovered a new way to help the immune system fight ovarian cancer by changing how tumors communicate with nearby immune cells.

Study Highlights Dangers of Alcohol Use and Risk for Colorectal Cancer

Mega Doctor News CLEVELAND CLINIC - Research continues to show the negative impact...

Researchers Uncover Why Colorectal Tumors Rely on Sugar to Grow

Despite advances in surgery and therapies, patients with metastatic colorectal cancer continue to have poor outcomes, highlighting the need for novel treatments.

Cedars‑Sinai Develops AI Platform to Guide Pancreatic Cancer Treatment Choices

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.
- Advertisement -